Similar articles

• Pre-cystectomy chemotherapy with sequentially administered cisplatin, cyclophosphamide and adriamycin in invasive transitional cell carcinoma of the bladder (preliminary report).

  Guazzieri S, Sperandio P, Fandella A, Garbeglio A, Pegoraro V, Chiarion V, Fiorentino M, Pagano F. Guazzieri S, et al. Prog Clin Biol Res. 1988;260:599-602. Prog Clin Biol Res. 1988. PMID: 3362909 No abstract available.
• [Evaluation of chemotherapy in advanced urothelial carcinoma: with special reference to combination chemotherapy with adriamycin, cyclophosphamide and cisplatin (ACE chemotherapy)].

  Tobisu K, Matsumoto K, Takai K, Kakizoe T. Tobisu K, et al. Nihon Hinyokika Gakkai Zasshi. 1987 Feb;78(2):327-34. Nihon Hinyokika Gakkai Zasshi. 1987. PMID: 3613336 Japanese. No abstract available.
• Adjuvant chemotherapy for invasive urothelial cancer: experience with a methotrexate, vincristine, cisplatin, cyclophosphamide, adriamycin and bleomycin (MVP-CAB) regimen: a preliminary report.

  Gohji K, Higuchi A, Maruyama S, Minayoshi K, Fujii A, Itoh N, Hasunuma Y, Tanaka H, Izumi T. Gohji K, et al. Jpn J Clin Oncol. 1993 Oct;23(5):291-8. Jpn J Clin Oncol. 1993. PMID: 7693990 Clinical Trial.
• Impact of methotrexate, vinblastine, adriamycin, and cisplatin chemotherapy in patients with lymph node metastases from transitional cell carcinoma of the lower urinary tract.

  Koch MO, Coussens D. Koch MO, et al. Semin Urol. 1993 Feb;11(1):14-9. Semin Urol. 1993. PMID: 8465122 Review. No abstract available.
• [Polychemotherapy treatment with cisplatin, adriamycin, 5-fluorouracil (FAP) and cisplatin, adriamycin and cyclophosphamide (CISCA) in advanced transitional carcinoma of the bladder].

  Sánchez Romero JA, Ramírez Ruiz F, Romero Fernández L, Pastor Gaitán P, Murillo Capitán E. Sánchez Romero JA, et al. Actas Urol Esp. 1989 Jul-Aug;13(4):240-2. Actas Urol Esp. 1989. PMID: 2678934 Review. Spanish.